Invesco
TNXP icon

Invesco’s Tonix Pharmaceuticals TNXP Stock Holding History

Invesco’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$481K Buy
37,691
+22,426
+147% +$289K ﹤0.01% 3255
2026
Q1 		$210K Buy
+15,265
New +$235K ﹤0.01% 3470
2022
Q2 		– Hold
0
– -$32K – 4144
2022
Q1 		– Hold
0
– – – 3962
2021
Q4 		– Hold
0
– – – 3996
2021
Q3 		– Hold
0
– – – 3985
2021
Q2 		– Hold
0
– – – 3899
2015
Q1 		– Hold
0
– -$62K – 4069
2014
Q4 		– Hold
0
– – – 3888

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco's TNXP Position: Q2 2026 in Review

Invesco increased its Tonix Pharmaceuticals (TNXP) stake by 147% in Q2 2026, buying an estimated $289K and bringing the position to 37,691 shares worth $481K. The position accounts for ﹤0.01% of the portfolio, ranked #3255.

Invesco first reported a position in TNXP in Q1 2026 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Invesco held 37,691 shares of Tonix Pharmaceuticals worth $481K as of Q2 2026.
  • Invesco bought 22,426 Tonix Pharmaceuticals shares in Q2 2026, an estimated $289K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3255 holding.
  • Invesco first reported a position in Tonix Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.